Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
3F., NO. 607, Ruiguang Rd., Neihu Dist., Taipei City, , 11492, TW
Agreement provides Takeda with exclusive access to ENHANZE drug delivery technology.
By: Charlie Sternberg
Will support Skye's evaluation of higher nimacimab subcutaneous doses for the treatment of obesity.
Iglesias will lead global medical affairs for botensilimab (BOT) and balstilimab (BAL).
This is the world’s first liquid formulation of IV infliximab and is available in 100 mg and 350 mg vials.
By: Rachel Klemovitch
Merus has licensed Halozyme's ENHANZE drug delivery technology for the development and potential commercialization of subcutaneous administration of petosemtamab.
Tyruko (natalizumab) is the first and only biosimilar for Multiple Sclerosis.
Will integrate Mabqi’s antibody discovery capabilities with Abzena’s development and manufacturing services.
By: Kristin Brooks
To develop monoclonal antibody biomanufacturing innovations and produce an anti-filovirus medical countermeasure.
Initiates global Phase 2/3 study of izalontamab brengitecan (iza-bren) in triple negative breast cancer.
Avtozma was FDA-approved in January 2025 to treat the same conditions as the reference product Actemra (tocilizumab).
The new facility has integrated and set up several solutions from Thermo Fisher’s portfolio.
Pexegra and Filra will be available with support from JAMP’s commercialization efforts in Canada.
Integrated trial management platform now offers a complete, end-to-end trial technology solution.
Pertuzumab uses Enzene’s fully-connected continuous manufacturing (FCCM) technology.
Aims to advance siRNA therapy for cardiovascular disorders.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
